Colorectal Cancer Screening Disparities Found in Hispanic/Latino Communities

New Cleveland Clinic research shows there are disparities when it comes to colorectal cancer screenings for the Hispanic and Latino communities here in the United States.

Translate to Spanish or other 102 languages!

Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings. Image for illustration purposes
Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings.

It appears they have lower screening rates.

“Colorectal cancer is one of the leading causes of cancer death among Hispanic or Latino populations, and so it is an extremely important public health problem,” explained Blake Buchalter, PhD, researcher for Cleveland Clinic.

- Advertisement -

Buchalter, who led the research team, said they developed an interactive map to determine which populations had the lowest colorectal cancer screening rates.

They also examined different component groups, such as the Cuban population, Mexican population, and Dominican population.

Buchalter said it’s unclear why exactly there are disparities in colorectal cancer screenings in the Hispanic and Latino communities.

That’s something that needs to be further studied.

- Advertisement -

In the meantime, he hopes the data can be used to help improve rates of colorectal cancer screenings.

“Policy makers, public health practitioners, and the public can actually go online and look at this [interactive map} and sort of see what these relationships look like in different geographic regions of the United States. And then that helps to basically identify these areas where funding or other policies could be targeted,” said Buchalter.

Currently, it’s recommended that adults start getting regular colorectal cancer screenings when they turn 45.

Those with an increased risk or who have a family history may need to get screened sooner.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

Why Science Says to Ditch Hydrogen Peroxide for Wounds

Growing up, you may have heard that you should treat open wounds with hydrogen peroxide, but that’s no longer the case.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- Advertisement -